Revlimid® (lenalidomide) – PRODUCT INFORMATION

REVLIMID is indicated for the treatment of patients who have myelodysplastic syndrome (MDS). Patients with MDS have bone marrow that does not produce enough mature blood cells. This causes a lack of healthy blood cells that can function properly in the body. REVLIMID helps promote immune responses to prevent inflammation and treats anemia.

For more information, please visit revlimid.com

Revlimid is a registered trademark of Celgene Corporation.